Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Anka C. Röhr"'
Autor:
Ute Chiriac, Daniel Richter, Otto R. Frey, Anka C. Röhr, Sophia Helbig, Stefan Hagel, Uwe Liebchen, Markus A. Weigand, Alexander Brinkmann
Publikováno v:
Antibiotics, Vol 12, Iss 7, p 1112 (2023)
Various studies have reported insufficient beta-lactam concentrations in critically ill patients. The optimal dosing strategy for beta-lactams in critically ill patients, particularly in septic patients, is an ongoing matter of discussion. This retro
Externí odkaz:
https://doaj.org/article/5689093f639e4ab4a532bf7386c1ddbf
Autor:
Hendrik Booke, Otto R. Frey, Anka C. Röhr, Ute Chiriac, Kai Zacharowski, Tomas Holubec, Elisabeth H. Adam
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract The scope of extracorporeal membrane oxygenation (ECMO) is expanding, nevertheless, pharmacokinetics in patients receiving cardiorespiratory support are fairly unknown leading to unpredictable drug concentrations. Currently, there are no cle
Externí odkaz:
https://doaj.org/article/50dee264d34a4e94a6aa66b22bf86e69
Autor:
Ute Chiriac, Heike Rau, Otto R. Frey, Anka C. Röhr, Sabrina Klein, Anna L. Meyer, Benedict Morath
Publikováno v:
Antibiotics, Vol 11, Iss 5, p 541 (2022)
Dalbavancin is emerging as a promising alternative in the ambulant treatment of gram-positive infections that require long-term antibiotic treatment such as osteomyelitis, prosthetic joint infections, and endocarditis. The aim of the current study wa
Externí odkaz:
https://doaj.org/article/56a674f9e2f343c08114866df33ae39e
Autor:
Christoph Tiede, Ute Chiriac, Daniel Dubinski, Florian J. Raimann, Otto R. Frey, Anka C. Röhr, Anna Wieduwilt, Michael Eibach, Natalie Filmann, Christian Senft, Kai Zacharowski, Volker Seifert, Jan Mersmann
Publikováno v:
Antibiotics, Vol 10, Iss 11, p 1421 (2021)
Effective antibiotic therapy of cerebral infections such as meningitis or ventriculitis is hindered by low penetration into the cerebrospinal fluid (CSF). Because continuous infusion of meropenem and vancomycin and routine therapeutic drug monitoring
Externí odkaz:
https://doaj.org/article/73c1a0fba63e4d55a69f5689187453a4
Autor:
Christina König, Anna Both, Holger Rohde, Stefan Kluge, Otto R. Frey, Anka C. Röhr, Dominic Wichmann
Publikováno v:
Antibiotics, Vol 10, Iss 10, p 1230 (2021)
1.1 Based on the initial data from Table 1 there were errors in the original article [...]
Externí odkaz:
https://doaj.org/article/2cd7f73ba3a04adaa36c68a0d3839ab3
Autor:
Ute Chiriac, Daniel C. Richter, Otto R. Frey, Anka C. Röhr, Sophia Helbig, Judit Preisenberger, Stefan Hagel, Jason A. Roberts, Markus A. Weigand, Alexander Brinkmann
Publikováno v:
Antibiotics, Vol 10, Iss 6, p 667 (2021)
Optimization of antibiotic dosing is a treatment intervention that is likely to improve outcomes in severe infections. The aim of this retrospective study was to describe the therapeutic exposure of steady state piperacillin concentrations (cPIP) and
Externí odkaz:
https://doaj.org/article/2a80fd75a77f4ee6a9c9ff071b7630b3
Autor:
Christina König, Anna Both, Holger Rohde, Stefan Kluge, Otto R. Frey, Anka C. Röhr, Dominic Wichmann
Publikováno v:
Antibiotics, Vol 10, Iss 6, p 649 (2021)
Cefiderocol is a new siderophore-cephalosporin for the treatment of multi-drug resistant Gram-negative pathogens. As a reserve agent, it will and should be used primarily in critically ill patients in the upcoming years. Due to the novelty of the sub
Externí odkaz:
https://doaj.org/article/8e3f0770f6364e47a2896eb12d27279f
Autor:
Julia Zimmer, Anka C. Röhr, Stefan Kluge, Jonas Faller, Otto R. Frey, Dominic Wichmann, Christina König
Publikováno v:
Antibiotics, Vol 10, Iss 3, p 242 (2021)
Cefiderocol is a new siderophore cephalosporin approved for the treatment of multidrug resistant bacteria including activity against carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa. As cephalosporins are known for their high pharmaco
Externí odkaz:
https://doaj.org/article/0903cd4689b44c33b51db1fcec40fc17
Publikováno v:
Krankenhaushygiene up2date. 16:187-201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c21817e781348d637407913ae9e0477
https://doi.org/10.1055/a-1173-5813
https://doi.org/10.1055/a-1173-5813
Autor:
Kai Zacharowski, Christoph Tiede, Florian J Raimann, Daniel Dubinski, Christian Senft, Natalie Filmann, Ute Chiriac, Otto R Frey, Anna Wieduwilt, Volker Seifert, Michael Eibach, Jan Mersmann, Anka C Röhr
Publikováno v:
Antibiotics, Vol 10, Iss 1421, p 1421 (2021)
Antibiotics
Volume 10
Issue 11
Antibiotics
Volume 10
Issue 11
Effective antibiotic therapy of cerebral infections such as meningitis or ventriculitis is hindered by low penetration into the cerebrospinal fluid (CSF). Because continuous infusion of meropenem and vancomycin and routine therapeutic drug monitoring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce24ee8f25d567347b977d6e9b172378
https://www.mdpi.com/2079-6382/10/11/1421
https://www.mdpi.com/2079-6382/10/11/1421